$32.75
0.030.09%
À la fermeture: -
$32.50
-0.25-0.76%
Après les heures de négociation: 7:57 PM EDT
Comments
Loading...
Orientation et prévision
Genmab publie des prévisions sur le BPA et les revenus futurs, donnant aux investisseurs un aperçu du montant que la société s'attend à gagner au cours des prochaines périodes.
Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
08/07/2025 | GMAB | Genmab | FY | 2025 | — | — | — | $3.50B | $3.70B | $15.41B | |
05/08/2025 | GMAB | Genmab | FY | 2025 | — | — | — | $3.34B | $3.66B | $3.71B | |
02/12/2025 | GMAB | Genmab | FY | 2025 | — | — | — | $3.34B | $3.66B | $3.51B | |
11/06/2024 | GMAB | Genmab | FY | 2024 | — | — | — | $3.11B | $3.20B | $3.08B | |
08/08/2024 | GMAB | Genmab | FY | 2024 | — | — | — | $2.96B | $3.13B | $2.89B | |
05/02/2024 | GMAB | Genmab | FY | 2024 | — | — | — | $2.72B | $2.98B | $2.84B | |
02/14/2024 | GMAB | Genmab | FY | 2024 | — | — | — | $2.70B | $2.96B | $2.76B | |
11/07/2023 | GMAB | Genmab | FY | 2023 | — | — | — | $2.32B | $2.41B | $2.30B | |
07/28/2023 | GMAB | Genmab | FY | 2023 | — | — | — | $2.27B | $2.41B | $2.38B | |
05/10/2023 | GMAB | Genmab | FY | 2023 | — | — | — | $1.94B | $2.13B | $2.31B | |
02/22/2023 | GMAB | Genmab | FY | 2023 | — | — | — | $1.94B | $2.13B | $2.44B | |
11/09/2022 | GMAB | Genmab | FY | 2022 | — | — | — | $1.83B | $1.97B | $1.72B | |
11/03/2022 | GMAB | Genmab | FY | 2022 | — | — | — | $1.88B | $2.01B | $1.68B | |
08/10/2022 | GMAB | Genmab | FY | 2022 | — | — | — | $1.72B | $1.86B | — | |
08/08/2022 | GMAB | Genmab | FY | 2022 | — | — | — | $1.72B | $1.86B | — | |
05/11/2022 | GMAB | Genmab | FY | 2022 | — | — | — | $1.66B | $1.81B | — | |
02/16/2022 | GMAB | Genmab | FY | 2022 | — | — | — | $1.66B | $1.85B | $1.68B | |
11/10/2021 | GMAB | Genmab | FY | 2021 | — | — | — | $1.32B | $1.42B | $1.27B | |
11/04/2021 | GMAB | Genmab | FY | 2021 | — | — | — | $1.25B | $1.35B | $1.27B | |
08/11/2021 | GMAB | Genmab | FY | 2021 | — | — | — | $1.18B | $1.28B | $1.27B | |
02/23/2021 | GMAB | Genmab | FY | 2021 | — | — | — | $1.09B | $1.20B | $1.30B |
FAQ
Quelles sont les dernières directives pour Genmab (GMAB) ?
Il n'y a eu aucune orientation spécifique sur les ventes ou les bénéfices rapportée pour Genmab ces derniers mois.
Parcourir guidance et prévisions sur toutes les actions.